Breaking news

Cyprus Plans 94 New Electric Vehicle Fast-Charging Points By 2028

by THEFUTURE.TEAM

October 26, 2026

Cyprus plans to add 94 fast-charging points for electric vehicles by 2028, in an investment estimated at €10 million. The Transport Ministry’s programme includes 76 chargers for light vehicles and 18 for heavy vehicles, with sites selected to extend coverage across the island’s road network.

A Phased Rollout Across The Island

The plan identifies 10 charging locations for light vehicles and three for heavy vehicles. Alongside urban centres in Nicosia, Larnaca and Limassol, the selected areas include Alambra, Kofinou, Evrychou, Saittas, Mandria in Paphos district, Polis Chrysochous and Paralimni.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

The schedule calls for 16 fast-charging points for light vehicles in 2026. In 2027, a further 48 points for light vehicles and 12 for heavy vehicles are planned. The remaining 18 chargers are expected to be installed in 2028.

Transport, Communications and Works Minister Evanthia Tsolaki outlined the programme in a response dated October 7, 2026, to Larnaca MP Prodromos Alambritis. She said the necessary funding for the 2026 and 2027 infrastructure has been included in the budget of the Department of Electrical and Mechanical Services.

Charger Capacity And Existing Network

Each of the 76 chargers for light vehicles will have a capacity of 150 kW. Of the 18 chargers for heavy vehicles, 12 will deliver 350 kW and the remaining six will provide 200 kW.

Cyprus currently has 384 publicly accessible charging points across 221 stations, according to the department. Nicosia has 76 stations, Limassol 57, Paphos 32, Larnaca 29 and Famagusta 27.

Infrastructure Already Installed

Ten fast-charging stations have already been installed at publicly accessible sites through the Recovery and Resilience Plan. The locations include the general hospitals in Nicosia, Larnaca, Limassol, Kyperounta and Famagusta; Troodos Square; the Choirokoitia archaeological site; Trimiklini; the Tombs of the Kings bus station in Paphos; and the Polis Chrysochous bus station.

The cost of these installations was €840,660, including VAT and five years of maintenance.

A separate 100 kW fast charger was installed at the Kato Pyrgos fishing shelter as part of efforts to revitalise Tylliria and position Kato Pyrgos as a green community. The station can charge two vehicles simultaneously. The project cost €77,000, including VAT and five years of maintenance.

From 2022 to 2026, a further 212 charging points were installed at publicly accessible sites, businesses and local authorities through the Electric Mobility With 1,000 grant scheme.

Public And Private Investment

Tsolaki said the expansion of electric mobility depends not only on the public charging network but also on private chargers at homes and businesses. These installations can also draw on electricity generated by solar photovoltaic systems.

The minister left open the possibility of further infrastructure investment as demand and market conditions evolve, signalling that the current programme may be only one stage in Cyprus’s broader transition to electric transport.

The Future Forbes Realty Global Properties

Blood Proteins May Signal Prostate Cancer Risk More Than 15 Years Before Diagnosis

by THEFUTURE.TEAM

October 27, 2026

Distinctive proteins in men’s blood may offer clues to prostate cancer risk more than 15 years before a diagnosis, according to research from the University of Oxford. The findings could help scientists better understand why some prostate cancers become aggressive while others grow slowly and never cause serious harm.

Researchers analyzed blood samples from 2,555 men collected between 1992 and 2000. Of those participants, 982 were later diagnosed with prostate cancer; the remaining 1,573 served as a comparison group. The team measured more than 6,000 proteins in the samples, which had been collected years—and, in some cases, more than 15 years—before diagnosis.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Protein Patterns Were Linked To Different Risks

The analysis identified proteins associated with prostate cancer risk overall, as well as proteins linked specifically to more aggressive or fast-growing forms of the disease. Higher levels of certain immune-system proteins, including GZMK and ANXA2, were associated with a lower long-term risk.

“Finding proteins linked to known prostate cancer driver genes in blood collected years before diagnosis gives us new insights into the earliest stages of the disease,” said Karl Smith-Byrne, the study’s corresponding author at Oxford.

The results, published in European Urology, are significant because prostate cancer is not a single, uniform disease. Many tumors grow slowly and may never threaten a patient’s health, while others progress rapidly and can be life-threatening. A clearer way to distinguish between these outcomes could eventually help improve how clinicians assess risk.

Promising Findings, Not A Screening Test

The researchers stressed that the protein patterns are not ready to be used as a screening test. The associations need further validation before they can inform clinical decisions, and the study does not establish that the proteins cause cancer or that measuring them can predict an individual’s outcome.

“Ultimately, we hope this will help us understand the biology of aggressive prostate cancer and identify markers that could improve how we assess risk in the future,” said first author Zhe Huang, a postdoctoral epidemiologist at Oxford Population Health.

Research Could Point To New Prevention Strategies

Prostate cancer is the most commonly diagnosed cancer among men in the European Union and the second most common worldwide, after lung cancer. In the EU, approximately 330,000 cases are diagnosed and 75,000 men die from the disease each year.

By identifying biological signals that appear long before diagnosis, the research may help scientists investigate the pathways involved in aggressive disease. Smith-Byrne said that, alongside existing and future genetic evidence, the findings could help reveal pathways that might ultimately be targeted to prevent aggressive prostate cancer.